Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Tirzepatide, a dual GIP/GLP-1 receptor agonist, represents the newest class of weight loss medications with remarkable clinical trial results from the SURMOUNT studies (Jastreboff et al., NEJM, 2022)
If you prefer not to take it before working out, you can spread out your dose and take it with meals
Clinical trials show tirzepatide produces greater average weight loss (22.5% vs 14.9% of body weight [1] )
Reputed companies have modern production facilities, advanced manufacturing procedures and strict quality control standards, which ensure consistency in all product batches
In case of accidental overdose, call a doctor or poison control center immediately
How to save on Wegovy Wegovy does not have a more affordable generic version, but there are still ways to save on brand-name drugs
